PharmaShots Weekly Snapshots (June 21 - 25, 2021)
Published: June 25, 2021 | Tags: Regeneron, Sanofi, Libtayo, cemiplimab, EC, Approval, Advanced Basal Cell Carcinoma
Published: June 25, 2021 | Tags: Regeneron, Sanofi, Libtayo, cemiplimab, EC, Approval, Advanced NSCLC
Published: June 25, 2021 | Tags: Roche, Actemra, RoActemra, tocilizumab, US, FDA, EUA, COVID-19
Published: June 25, 2021 | Tags: AbbVie, CHMP, Approval, Rinvoq, upadacitinib, Atopic Dermatitis
Published: June 25, 2021 | Tags: Lilly, Donanemab, US, FDA, Breakthrough Therapy Designation, Alzheimer Disease
Published: June 25, 2021 | Tags: AbbVie, Acquire, TeneoOne, TNB-383B, Multiple Myeloma
Tecan to Acquire Paramit for ~$1.0B
Published: June 24, 2021 | Tags: Tecan, Acquire, Paramit, ~$1.0B
Published: June 24, 2021 | Tags: Janssen, NDA, US, FDA, Xarelto, rivaroxaban, Venous Thromboembolism, Children
Chugai's Evrysdi (risdiplam) Receives MHLW's Approval for the Treatment of Spinal Muscular Atrophy
Published: June 24, 2021 | Tags: Chugai, Evrysdi, risdipla, MHLW, Approval, Spinal Muscular Atrophy
Bayer's Verquvo (vericiguat) Receives MHLW's Approval for Chronic Heart Failure
Published: June 24, 2021 | Tags: Bayer, Verquvo, vericiguat, MHLW, Approval, Chronic Heart Failure
Published: June 24, 2021 | Tags: Eisai, Biogen, FDA, Breakthrough Therapy Designation, Lecanemab, BAN2401, Alzheimer Disease
Published: June 24, 2021 | Tags: Roche, US, FDA, BLA, Port Delivery System, Ranibizumab, Neovascular Age-Related Macular Degeneration
Sorrento Enters a Multi-Year Research and Development Agreement with US NAMRU-3 Against COVID-19
Published: June 23, 2021 | Tags: Sorrento, Research, Development Agreement, US, NAMRU-3, COVID-19
Pear Therapeutics to Become Public Via THMA SPAC Merger for ~$1.6B
Published: June 23, 2021 | Tags: Pear, Public, THMA, SPAC Merger, ~$1.6B, PDTs
uniQure to Acquire Corlieve Therapeutics for $55M
Published: June 23, 2021 | Tags: uniQure, Acquire, Corlieve Therapeutics, $55M, Upfront Payment
Published: June 23, 2021 | Tags: uniQure, Etranacogene Dezaparvovec, P-III, HOPE-B Trial, Hemophilia B
Novartis Reports New Data of Kesimpta (ofatumumab) in ALITHIOS Study for Multiple Sclerosis
Published: June 23, 2021 | Tags: Novartis, Kesimpta, ofatumumab, ALITHIOS Study, Multiple Sclerosis
LEO Pharma' Adtralza (tralokinumab) Receives EC's Approval for Moderate-To-Severe Atopic Dermatitis
Published: June 23, 2021 | Tags: LEO Pharma, Adtralza, tralokinumab, EC, Approval, Atopic Dermatitis
Published: June 22, 2021 | Tags: GSK, Vir, Sotrovimab, P-III, COMET-ICE Trial, COVID-19
Published: June 22, 2021 | Tags: ViiV Healthcare, License Agreement, Halozyme, ENHANZE Drug Delivery Technology, Ultra Long-Acting Medicines, HIV
Published: June 22, 2021 | Tags: AstraZeneca, MSD, Koselugo, selumetinib, EU, Approval, Neurofibromatosis Type 1, Plexiform Neurofibromas
Published: June 22, 2021 | Tags: Innovent, Sintilimab, IBI305, biosimilar, bevacizumab, P-II/III, ORIENT-32 Study, HCC, The Lancet Oncology
Published: June 22, 2021 | Tags: Arrowhead, License Agreement, Horizon Therapeutics, Develop, siRNA Therapeutic, XDH Uncontrolled Gout
Published: June 22, 2021 | Tags: Bayer, sNDA, Copanlisib, Rituximab, US, FDA, MAA, EMA, B-iNHL, Relapsed MZL, EU
Published: June 21, 2021 | Tags: FibroGen, HiFiBiO, Next-Generation Therapies, Cancer, Autoimmune Disease
Published: June 21, 2021 | Tags: BeiGene, Brukinsa, zanubrutinib, NMPA, Approval, Waldenström's Macroglobulinemia, WM
Eisai Collaborates with BMS for the Co-Development and Co-Commercialization of MORAb-202
Published: June 21, 2021 | Tags: Eisai, BMS, Co-Development, Co-Commercialization, MORAb-202
Novartis Presents New Data of Zolgensma in P-III Studies in Symptomatic Children with SMA at EAN2021
Published: June 21, 2021 | Tags: Novartis, Zolgensma, P-III, SPR1NT Two-Copy Cohort Trial, SMA, EAN2021
Published: June 21, 2021 | Tags: BMS, Onureg, azacytidine, EC, Approval, Acute Myeloid Leukemia
Published: June 21, 2021 | Tags: Sanofi, Aubagio, teriflunomide, EC, Approval, Relapsing-Remitting Multiple Sclerosis
Related Post: PharmaShots Weekly Snapshots (June 14 - 18, 2021)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com